[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]
- PMID: 26831807
- DOI: 10.1248/yakushi.15-00214
[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]
Abstract
Peripheral neuropathy is a common adverse effect of paclitaxel and oxaliplatin treatment. The major dose-limiting side effect of these drugs is peripheral sensory neuropathy. The symptoms of paclitaxel-induced neuropathy are mostly sensory and peripheral in nature, consisting of mechanical allodynia/hyperalgesia, tingling, and numbness. Oxaliplatin-induced neurotoxicity manifests as rapid-onset neuropathic symptoms that are exacerbated by cold exposure and as chronic neuropathy that develops after several treatment cycles. Although many basic and clinical researchers have studied anticancer drug-induced peripheral neuropathy, the mechanism is not well understood. In this review, we focus on (1) analysis of transient receptor potential vanilloid 1 (TRPV1) channel expression in the rat dorsal root ganglion (DRG) after paclitaxel treatment and (2) analysis of transient receptor potential ankyrin 1 (TRPA1) channel in the DRG after oxaliplatin treatment. This review describes that (1) paclitaxel-induced neuropathic pain may be the result of up-regulation of TRPV1 in small- and medium-diameter DRG neurons. In addition, paclitaxel treatment increases the release of substance P, but not calcitonin gene-related peptide, in the superficial layers of the spinal dorsal horn. (2) TRPA1 expression via activation of p38 mitogen-activated protein kinase in small-diameter DRG neurons, at least in part, contributes to the development of oxaliplatin-induced acute cold hyperalgesia. We suggest that TRPV1 or TRPA1 antagonists may be potential therapeutic lead compounds for treating anticancer drug-induced peripheral neuropathy.
Similar articles
-
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.Mol Pain. 2010 Mar 5;6:15. doi: 10.1186/1744-8069-6-15. Mol Pain. 2010. PMID: 20205720 Free PMC article.
-
Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.Neurosci Lett. 2022 Mar 16;773:136512. doi: 10.1016/j.neulet.2022.136512. Epub 2022 Feb 8. Neurosci Lett. 2022. PMID: 35149198
-
Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity.Neuropeptides. 2018 Feb;67:95-101. doi: 10.1016/j.npep.2017.12.002. Epub 2017 Dec 15. Neuropeptides. 2018. PMID: 29274843
-
Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy.Biol Pharm Bull. 2017;40(7):947-953. doi: 10.1248/bpb.b17-00243. Biol Pharm Bull. 2017. PMID: 28674258 Review.
-
[Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].Brain Nerve. 2008 May;60(5):483-92. Brain Nerve. 2008. PMID: 18516970 Review. Japanese.
Cited by
-
Berberine Alleviate Cisplatin-Induced Peripheral Neuropathy by Modulating Inflammation Signal via TRPV1.Front Pharmacol. 2022 Jan 26;12:774795. doi: 10.3389/fphar.2021.774795. eCollection 2021. Front Pharmacol. 2022. PMID: 35153744 Free PMC article.
-
Probiotic DSF counteracts chemotherapy induced neuropathic pain.Oncotarget. 2018 Jun 15;9(46):27998-28008. doi: 10.18632/oncotarget.25524. eCollection 2018 Jun 15. Oncotarget. 2018. PMID: 29963257 Free PMC article.
-
Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.Int J Mol Sci. 2021 Mar 10;22(6):2802. doi: 10.3390/ijms22062802. Int J Mol Sci. 2021. PMID: 33802143 Free PMC article. Review.
-
Experimental Drugs for Neuropathic Pain.Curr Neuropharmacol. 2018;16(8):1193-1209. doi: 10.2174/1570159X16666180510151241. Curr Neuropharmacol. 2018. PMID: 29745335 Free PMC article. Review.
-
TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain.Pain. 2023 Sep 1;164(9):2060-2069. doi: 10.1097/j.pain.0000000000002906. Epub 2023 Apr 19. Pain. 2023. PMID: 37079852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical